|
⚲
|
| Oncogenex Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000949858 |
| Sale | 2009-12-24 ($10.0 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 4254879500 |
| Address | 1522 217th Place SE Bothell, 98021 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Dwight Winstead | |
| Michelle Burris | |
| Neil Clendeninn | |
| Scott Cormack | |
| Stephen Anderson | |
| Michael Martino | |
| Cindy Jacobs |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Gravity Software, LLC
✚
|
0.0 | |
|
Daytona Investors, LP
✚
|
0.0 | |
|
Dealer Advance Group, L.L.C.
✚
|
0.0 | |
|
Solstice Biologics LLC
✚
|
0.0 | |
|
Soma Direct Trade, LLC
✚
|
0.0 | |
|
Gravity Ventures IV Indiana, LLC
✚
|
0.0 | |
|
Graybul Antioch, LP
✚
|
0.0 | |
|
Great Point Opportunity Fund A LP
✚
|
0.0 | |
|
Great Point Opportunity Fund B LP
✚
|
0.0 | |
|
Graves William P
✚
|
0.0 |